Welcome to the working week. We hope your weekend was pleasant and there was time to catch up on the important things. Now, of course, the routine returns. To prepare, we are brewing the required cup of stimulation. Meetings and deadlines await, so grab one yourself, or perhaps a water bottle will do. Meanwhile, here are a few items of interest. Have a good day, everyone...
Glaxo Prostate Drug Wins Swiss Approval (Reuters)
Sanofi's Multaq Tests Indicates Low Price In France (Bloomberg)
AstraZeneca And Xenome Strike Deal On Snail Venom (The Times of London)
Roche Seeks To Broaden Mabthera Use (Reuters)
Glaxo Tests Phase III Rolavair Asthma Trials (PharmaTimes)